Fundamentals data is not available for this company.
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-26 | 7.77 | (453.51) | (370.65)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-27 | 0.30 | (536.40) | (408.66)¢ | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2026 FactSet Research Systems Inc. All rights reserved.
| Viking Therapeutics soars 120% following positiv... | 18-Sep-2018 | ShareCast |
| Currency | US Dollars |
| Share Price | $ 35.18 |
| Change Today | $ 0.00 |
| % Change | 0.00 % |
| 52 Week High | $42.89 |
| 52 Week Low | $21.28 |
| Volume | 2,147,527 |
| Shares Issued | 72.03m |
| Market Cap | $2,533.93m |
| RiskGrade | 326 |
| Strong Buy | 7 |
| Buy | 9 |
| Neutral | 1 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 17 |

You are here: research